525 related articles for article (PubMed ID: 28991233)
1. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
2. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
[TBL] [Abstract][Full Text] [Related]
3. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
Muthamilselvan S; Raghavendran A; Palaniappan A
PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation markers in colorectal cancer.
Kim MS; Lee J; Sidransky D
Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
[TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.
Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M
Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252
[TBL] [Abstract][Full Text] [Related]
7. Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis.
Mäki-Nevala S; Ukwattage S; Wirta EV; Ahtiainen M; Ristimäki A; Seppälä TT; Lepistö A; Mecklin JP; Peltomäki P
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680073
[TBL] [Abstract][Full Text] [Related]
8. Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers.
Chong A; Teo JX; Ban KH
Oncotarget; 2016 May; 7(19):28027-39. PubMed ID: 27049830
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea.
Joe S; Kim J; Lee JY; Jeon J; Byeon I; Han SW; Ryoo SB; Park KJ; Song SH; Cho S; Shim H; Bao Khanh Chu H; Kang J; Lee HS; Kim D; Kim YJ; Kim TY; Kim SY
BMB Rep; 2023 Oct; 56(10):563-568. PubMed ID: 37574809
[TBL] [Abstract][Full Text] [Related]
10. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of endothelin-3 in colorectal cancer.
Olender J; Nowakowska-Zajdel E; Kruszniewska-Rajs C; Orchel J; Mazurek U; Wierzgoń A; Kokot T; Muc-Wierzgoń M
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):333-40. PubMed ID: 26684626
[TBL] [Abstract][Full Text] [Related]
12. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
14. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
[TBL] [Abstract][Full Text] [Related]
15. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
17. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
20. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]